Aug 10, 2018

Nurturing Future Cancer Researchers in the PathMaker Program

The PathMaker program is a stepping stone for students interested in a career in health sciences or STEM with backgrounds underrepresented in the biomedical workforce.

Jul 13, 2018

Huntsman Cancer Institute Names Cornelia Ulrich as Director of its Cancer Research Center

Huntsman Cancer Institute at the University of Utah today announced the appointment of Cornelia Ulrich, PhD, MS, as director of its National Cancer Institute-Designated Comprehensive Cancer Center. She will oversee HCI’s academic consortium of nearly 200 cancer research teams. Ulrich will lead efforts to advance HCI’s research in laboratory, clinical and population science, with the goal of improving cancer prevention and treatment.

Jun 11, 2018

Letter of Hope from the Gertz Lab

It is patients like you, your loved ones, and Dr. Gertz's parents who keep us motivated and excited to find ways to help in the fight against this terrible disease. We appreciate everything you do as patients—like donating samples and participating in clinical trials—and we want you to know that we are doing everything we can to help patients with breast and uterine cancer.

May 18, 2018

Space Could Be the New Frontier for Cancer Research

On May 16, 2018, HCI hosted a NASA astronaut and a team from the Center for the Advancement of Science in Space to discuss the opportunity of researching cancer in space.

Mar 13, 2018

Surprising Discovery Provides Insights into Aggressive Endometrial Cancers

New research from Huntsman Cancer Institute at the University of Utah indicates steroid and hormone receptors are simultaneously active in many endometrial cancer tissues. The findings, published today in the journal Cell Reports, yield insights about factors that contribute to more aggressive endometrial tumors.

Feb 27, 2018

New understanding of enzyme’s role in development of certain brain and spinal cord tumors

In a study recently published in Acta Neuropathologica, L. Eric Huang, MD, PhD, Huntsman Cancer Institute researcher and associate professor of neurosurgery at the University of Utah, and colleagues report on new findings in the function of an enzyme, IDH1, in the development of gliomas. Gliomas are life-threatening tumors of brain or spinal cord tissue, and this type of tumor affects approximately 25,000 people each year. As changes in IDH1 are found in the vast majority of gliomas, understanding the impact of IDH1 enzyme function is critical to advancing research in this disease.

Feb 15, 2018

Message from HCI's CEO

The West is known for its "can-do" spirit, for the willingness of people to work together. At Huntsman Cancer Institute, we strive to push the boundaries of cancer research and care and attain results beyond what we thought was possible. We've made a commitment to advance cutting-edge cancer research and care in the Mountain West region.

Feb 15, 2018

Developing Better Targeted Therapies

Targeted therapy in cancer treatment is often called personalized or precision medicine, according to the National Institutes of Health. Targeted therapies are designed to be more effective and less harmful than other approaches because the drugs are specially designed to meet the individual characteristics of each patient.